Edmund Fay
Known title: Sr. Vice Pres. and TreasurerCIK: 0001433234
Associated companies
Transaction History
| EHC | ▼ Sell | Open Market | 11,937 | $1.3M | 3/9/2026 | View on chart |
| EHC | ▼ Sell | Gift | 3,000 | $0 | 3/9/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 280 | $30K | 2/28/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 380 | $40K | 2/23/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 208 | $22K | 2/20/2026 | View on chart |
| EHC | ▲ Buy | Grant | 1,430 | $0 | 2/19/2026 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 3,479 | $373K | 2/19/2026 | View on chart |
| EHC | ▲ Buy | Grant | 7,690 | $0 | 2/18/2026 | View on chart |
| EHC | ▼ Sell | Gift | 3,667 | $0 | 5/14/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 276 | $28K | 2/28/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 384 | $39K | 2/25/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 374 | $36K | 2/24/2025 | View on chart |
| EHC | ▲ Buy | Grant | 1,404 | $0 | 2/20/2025 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 2,291 | $212K | 1/1/2025 | View on chart |
| EHC | ▲ Buy | Grant | 5,010 | $0 | 2/28/2024 | View on chart |
| EHC | ▲ Buy | Grant | 1,890 | $0 | 2/28/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 384 | $29K | 2/25/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 299 | $22K | 2/24/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 374 | $28K | 2/23/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 1,935 | $129K | 1/2/2024 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 383 | $23K | 2/27/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 299 | $18K | 2/24/2023 | View on chart |
| EHC | ▲ Buy | Grant | 4,125 | $0 | 2/23/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,563 | $0 | 2/23/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 278 | $17K | 2/21/2023 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 1,259 | $75K | 1/3/2023 | View on chart |
| EHC | ▲ Buy | Grant | 2,129 | $0 | 2/25/2022 | View on chart |
| EHC | ▲ Buy | Grant | 2,180 | $0 | 2/25/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 247 | $16K | 2/24/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 507 | $33K | 2/22/2022 | View on chart |
| EHC | ▼ Sell | Tax Withholding | 1,025 | $67K | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Encompass Health Sets Q3 2026 Earnings Call Date
Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.
Encompass Health Sets Q3 2026 Earnings Call Date. Encompass Health announced the date for its 2026 third-quarter earnings call. Recent coverage also highlights the company's small-format expansion strategy and potential undervaluation as it builds out its rehabilitation capacity. The stock is currently trading near the lower end of its 52-week range, with an average analyst target of $148.17.